Aimmune Therapeutics, Inc.
SEC CIK 1631650 · AIMT · last insider filing 2020-10-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Falberg Kathryn E | Director | filed 2015 - 2020 |
| Mcdade Mark | Director | filed 2015 - 2020 |
| Enright Patrick G | Director | filed 2015 - 2020 |
| Iwicki Mark T | Director | filed 2015 - 2020 |
| Haumann Brett K | Director | filed 2018 - 2020 |
| Behar Gregory | Director | filed 2016 - 2020 |
| Seltzer Stacey Denenberg | Director | filed 2015 - 2020 |
| Dallas Jayson Donald Alexander | Director · President and CEO | filed 2018 - 2020 |
| Dilly Stephen George | Director · See Remarks | filed 2015 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bjerkholt Eric | Chief Financial Officer | filed 2017 - 2020 |
| Adelman Daniel C MD | Chief Medical Officer | filed 2016 - 2020 |
| Sheehy Douglas T. | See Remarks | filed 2016 - 2020 |
| Oxtoby Andrew | Chief Commercial Officer | filed 2019 - 2020 |
| Rozenman Mary M. | See Remarks | filed 2015 - 2020 |
| Barrowcliffe Susan E. | General Manager, Europe | filed 2016 - 2018 |
| Knapp Jeffrey H | Chief Operating Officer | filed 2016 - 2018 |
| Desouza Warren L. | Chief Financial Officer | filed 2015 - 2017 |
| Elfont Robert Myles | Chief Medical Officer | filed 2015 - 2016 |
| Raff Howard V. | Chief Operating Officer | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.